Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
P. Kent Hawryluk | President CEO | 2025-10-20 | 20,000 | $13.64 | $272.78kBuy |
Steven L. Hoerter | Director | 2025-10-17 | 20,000 | $13.25 | $264.98kBuy |
Patrick J. Heron | Director | 2025-09-26 | 666,666 | $18.00 | $12.00MBuy |
Ora H. Pescovitz | Director | 2025-04-08 | 7,693 | $5.89 | $45.31kBuy |
Carl L. Gordon | Director | 2025-02-18 | 49,070 | $10.84 | $531.92kBuy |
Carl L. Gordon | Director | 2025-02-18 | 94,100 | $10.84 | $1.02MBuy |
Orbimed Advisors LLC | Director | 2025-02-18 | 49,070 | $10.84 | $531.92kBuy |
Orbimed Advisors LLC | Director | 2025-02-18 | 94,100 | $10.84 | $1.02MBuy |
Carl L. Gordon | Director | 2025-02-14 | 17,962 | $9.90 | $177.82kBuy |
Carl L. Gordon | Director | 2025-02-14 | 29,540 | $9.85 | $290.97kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Frazier Life Sciences Management LP | 17.91% | 5,985,347 | $85.17M | Institution |
Patrick J. Heron | 15.62% | 5,219,440 | $74.27M | Insider |
Orbimed Advisors LLC | 13.64% | 4,560,102 | $64.89M | Insider |
Carl L. Gordon | 13.64% | 4,560,102 | $64.89M | Insider |
Frazier Life Sciences X LP | 13.62% | 4,552,774 | $64.79M | Insider |
Orbimed Advisors LLC | 11.98% | 4,002,887 | $56.96M | Institution |
New Enterprise Associates 17 LP | 10.81% | 3,614,486 | $51.43M | Insider |
Edward T. Mathers | 10.81% | 3,614,486 | $51.43M | Insider |
Forest Baskett | 10.81% | 3,614,486 | $51.43M | Insider |
Ali Behbahani | 10.81% | 3,614,486 | $51.43M | Insider |